2022


Also found in: Wikipedia.

Holidays, Festivals, and Celebrations of the World in 2022

 
JanuaryFebruaryMarch
SMTWTFS SMTWTFS SMTWTFS
      1    1 2 3 4 5    1 2 3 4 5 
2 3 4 5 6 7 8  6 7 8 9 10 11 12  6 7 8 9 10 11 12 
9 10 11 12 13 14 15  13 14 15 16 17 18 19  13 14 15 16 17 18 19 
16 17 18 19 20 21 22  20 21 22 23 24 25 26  20 21 22 23 24 25 26 
23 24 25 26 27 28 29  27 28       27 28 29 30 31   
30 31                      
 
AprilMayJune
SMTWTFS SMTWTFS SMTWTFS
     1 2  1 2 3 4 5 6 7     1 2 3 4 
3 4 5 6 7 8 9  8 9 10 11 12 13 14  5 6 7 8 9 10 11 
10 11 12 13 14 15 16  15 16 17 18 19 20 21  12 13 14 15 16 17 18 
17 18 19 20 21 22 23  22 23 24 25 26 27 28  19 20 21 22 23 24 25 
24 25 26 27 28 29 30  29 30 31      26 27 28 29 30   
                       
 
JulyAugustSeptember
SMTWTFS SMTWTFS SMTWTFS
     1 2   1 2 3 4 5 6      1 2 3 
3 4 5 6 7 8 9  7 8 9 10 11 12 13  4 5 6 7 8 9 10 
10 11 12 13 14 15 16  14 15 16 17 18 19 20  11 12 13 14 15 16 17 
17 18 19 20 21 22 23  21 22 23 24 25 26 27  18 19 20 21 22 23 24 
24 25 26 27 28 29 30  28 29 30 31     25 26 27 28 29 30  
31                       
 
OctoberNovemberDecember
SMTWTFS SMTWTFS SMTWTFS
      1    1 2 3 4 5      1 2 3 
2 3 4 5 6 7 8  6 7 8 9 10 11 12  4 5 6 7 8 9 10 
9 10 11 12 13 14 15  13 14 15 16 17 18 19  11 12 13 14 15 16 17 
16 17 18 19 20 21 22  20 21 22 23 24 25 26  18 19 20 21 22 23 24 
23 24 25 26 27 28 29  27 28 29 30     25 26 27 28 29 30 31 
30 31                      
References in periodicals archive ?
By the mid-to-late term of GlobalData's 2012 to 2022 forecast, Sanofi/Regeneron's dupilumab is expected to reshape the moderate and severe treatment landscape.
PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022 http://www.
Annualized seasonal influenza vaccine market revenue, annual cost of vaccination and treatment usage pattern data from 2012 and forecast for ten years to 2022.
com announces that a new market research report is available in its catalogue: PharmaPoint: Osteoporosis - Global Drug Forecast and Market Analysis to 2022 http://www.
PharmaPoint: Alzheimer's Disease - Global Drug Forecast and Market Analysis to 2022 http://www.
These shifts lead a $305 billion 2011 market to a $546 billion by 2022.
BMS's nivolumab will emerge as the overall market leader in 2022, launching first in the second-line segment in 2016 and expanding into the first-line segment in 2019.
The IOCos Evaluation Commission report - released last Monday - was a welcomed recognition for the Almaty 2022 bid's plan.
com announces that a new market research report is available in its catalogue: by Geography - Global Forecasts to 2022 ag-applications--by-Geography Global-Forecasts-to-2022.
0% unsecured convertible notes (new notes) due 2022 that were offered in exchange for the outstanding 5.
com announces that a new market research report is available in its catalogue: PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update http://www.